New hope for lymphoma patients as experimental drug trial opens
NCT ID NCT07439653
Summary
This early-stage study is testing a new drug called TORL-5-700 for people with B-cell non-Hodgkin lymphoma that has come back or hasn't responded to other treatments. Researchers will give the drug alone and in combination with other medicines to about 155 participants to see if it's safe and if it can shrink tumors. The main goals are to find the right dose and check for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HISTOLOGICALLY CONFIRMED RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.